Status:

COMPLETED

Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)

Lead Sponsor:

Lahey Clinic

Conditions:

Progressive Supranuclear Palsy

Eligibility:

All Genders

30+ years

Phase:

NA

Brief Summary

The clinical syndrome of PSP responds poorly to all available forms of therapy used in Parkinson's Disease (PD). Currently, no effective treatment exists. Coenzyme Q10 in high doses has been shown to ...

Detailed Description

The study is designed as a multicenter randomized, placebo-controlled, double blind trial. Up to 60 patients with PSP will be enrolled at several centers in the United States

Eligibility Criteria

Inclusion

  • Patients fulfilling the diagnostic criteria of PSP/diagnosed within the past 5 years
  • Either vertical supranuclear palsy or both slowing of vertical saccades
  • Prominent postural instability with falls in the first year of disease onset
  • No evidence of other diseases that could explain the foregoing features

Exclusion

  • Current or previous therapeutic use of CoQ10
  • Parkinsonism due to drugs
  • History of pallidotomy, thalamotomy, active deep brain stimulator or fetal tissue transplant
  • History of active epilepsy, stroke, structural brain disease
  • Use of methylphenidate hydrochloride, cinnarizine, reserpine, amphetamines, or monoamine oxidase-A inhibitors within 3 months before the baseline visit.
  • Active cancer or cancer undergoing treatment
  • Participation in other drug studies or the use of other investigational drugs within 30 days before screening.
  • Known hypersensitivity to Coenzyme Q10.
  • Pregnant, planning a pregnancy or nursing woman

Key Trial Info

Start Date :

September 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2015

Estimated Enrollment :

61 Patients enrolled

Trial Details

Trial ID

NCT00382824

Start Date

September 1 2006

End Date

January 1 2015

Last Update

August 1 2019

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

University of Alabama

Birmingham, Alabama, United States, 35294

2

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

3

Lahey Clinic

Burlington, Massachusetts, United States, 01805